Analysis of the causes of XXXX swelling.

@entity1 @entity227 @entity6 @entity2479 @entity67414 @entity7995 @entity1781 @entity1829 @entity3856
PURPOSE: To investigate the clinical manifestations and diagnoses of @entity1781 swelling. METHODS: The medical records of 49 @entity1 who experienced @entity1781 swelling between March 2008 and June 2009 were retrospectively reviewed. The characteristics of non-arteritic anterior @entity1781 (NA-AION) and @entity7995 ( @entity7995 ), which showed @entity1781 swelling most commonly, were compared. RESULTS: NA-AION was the most common disorder (34.7%) that presented with @entity1781 swelling. @entity7995 was identified in 15 @entity1 (30.6%). Seven out of 49 @entity1 (14.3%) had intracranially associated diseases, such as @entity1829 and @entity1781 . @entity67414 was noted in four @entity1 (8.2%). Other diseases (e.g., papillophlebitis, @entity2479 , and @entity6 ) were seen in six @entity1 (12.2%). @entity3856 was observed more commonly in @entity1 with @entity7995 (p = 0.001). @entity1 with @entity7995 expected a better visual prognosis than @entity1 with NA-AION (0.12    0.32 vs. 0.49    0.35, p = 0.001). CONCLUSIONS: NA-AION and @entity7995 should be considered in the differential diagnosis when @entity1 with @entity1781 swelling present to the neuro-ophthalmology clinic. Detailed history taking and supportive examinations, such as @entity227 and imaging tests, should also be performed as indicated. Regular follow-up of such exams is necessary for the differential diagnosis of these diseases.
